SYNNEX Corp. (SNX) Tops Q3 EPS by 31c, Offers Guidance
Tweet
Share
E-mail
Get Alerts SNX Hot Sheet
Price: $255.21 --0%
EPS Growth %: +27.7%
Financial Fact:
Selling, general and administrative expenses: -227.94M
Today's EPS Names:
VAXX, NMRD, EGRX, More
EPS Growth %: +27.7%
Financial Fact:
Selling, general and administrative expenses: -227.94M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
SYNNEX Corp. (NYSE: SNX) reported Q3 EPS of $2.78, $0.31 better than the analyst estimate of $2.47. Revenue for the quarter came in at $14 billion versus the consensus estimate of $14.11 billion.
GUIDANCE:
SYNNEX Corp. sees Q4 2023 EPS of $2.40-$2.90, versus the consensus of $2.97. SYNNEX Corp. sees Q4 2023 revenue of $14-15 billion, versus the consensus of $15.2 billion.
For earnings history and earnings-related data on SYNNEX Corp. (SNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Legence Corp. (LGN) Misses Q2 EPS by 58c
- Telesat Corporation (TSAT) Misses Q2 EPS by 1006c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
